✦ LIBER ✦

PHC9 COST-EFFECTIVENESS OF RIVAROXABANVERSUS ENOXAPARIN FORTHROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT IN THE UK

✍ Scribed by A Diamantopoulos; F Forster; M Lees; L Gilmour; D Ashley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PHC6 COST-EFFECTIVENESS OF RIVAROXABANVE

✍ A Diamantopoulos; F Forster; M Brosa; M Lees; C Piñol; L Febrer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PHC7 COST-EFFECTIVENESS OF RIVAROXABANVE

✍ A Diamantopoulos; F Forster; M Lees; HP McDonald 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PHC8 COST-EFFECTIVENESS OF RIVAROXABANVE

✍ A Diamantopoulos; F Forster; M Brosa; M Lees; L Gilmour; D Ashley; C Piñol 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PCV11 COST-EFFECTIVENESS OF RIVAROXABAN

✍ Pereira, R; Duran, A; Lindner, L; Toro, W; Arango, CH 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PCV38 COST-EFFECTIVENESS OF RIVAROXABAN

✍ J Kim; R Pollock; S Jung; A Diamantopoulos; M Lees 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB